Pfizer Inc. (NYSE: PFE) Q4 2021 earnings call dated Feb. 08, 2022 Corporate Participants: Chris Stevo -- Senior Vice President and Chief Investor Relations
Pfizer Inc. (PFE) Q4 2021 Earnings Call Transcript
Categories
Health Care
PFE Earnings: All you need to know about Pfizer’s Q4 2021 earnings results
Pfizer Inc. (NYSE: PFE) reported fourth quarter 2021 earnings results today. Revenues doubled year-over-year to $23.8 billion. Excluding contributions from Comirnaty and
Ocean Biomedical slashes IPO size. Should you invest in the stock?
The biomedical industry grew at an accelerated pace in 2021 even as healthcare systems went into overdrive amidst the COVID-induced medical emergency.
Regeneron Pharmaceuticals Inc. (REGN) Q4 2021 Earnings Call Transcript
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Q4 2021 earnings call dated Feb. 04, 2022 Corporate Participants: Mark Hudson -- Director, Investor Relations Leonard S. Schleifer -- Founder,
Bristol Myers Squibb (BMY) Q4 Earnings: Key financials and quarterly highlights
Bristol Myers Squibb (NYSE: BMY) reported fourth quarter 2021 earnings results today. Total revenues increased 8% year-over-year to $12 billion, driven by
Merck & Co., Inc. (MRK) Q4 2021 Earnings Call Transcript
Merck & Co., Inc. (NYSE: MRK) Q4 2021 earnings call dated Feb. 03, 2022 Corporate Participants: Peter Dannenbaum -- Vice President of Investor Relations
Cigna Corporation (CI) Q4 2021 Earnings Call Transcript
Cigna Corporation (NYSE: CI) Q4 2021 earnings call dated Feb. 03, 2022 Corporate Participants: Ralph Giacobbe -- Investor Relations David Cordani -- Chairman and Chief Executive
Eli Lilly and Company (LLY) Q4 2021 Earnings Call Transcript
Eli Lilly and Company (NYSE: LLY) Q4 2021 earnings call dated Feb. 03, 2022 Corporate Participants: Kevin Hern — Investor Relations David A. Ricks — Chair
Biogen, Inc. (BIIB) Q4 2021 Earnings Call Transcript
Biogen, Inc. (NASDAQ: BIIB) Q4 2021 earnings call dated Feb. 03, 2022 Corporate Participants: Michael Hencke -- Head of Investor Relations Michel Vounatsos -- Chief Executive
Cardinal Health, Inc. (CAH) Q2 2022 Earnings Call Transcript
Cardinal Health, Inc. (NYSE: CAH) Q2 2022 earnings call dated Feb. 03, 2022 Corporate Participants: Kevin Moran -- Vice President of Investor Relations Mike
Infographic: A snapshot of Merck’s Q4 2021 earnings
Pharmaceuticals company Merck & Co., Inc. (NYSE: MRK) has reported stronger-than expected earnings and revenues for the fourth quarter. The positive outcome
BIIB Earnings: Key quarterly highlights from Biogen’s Q4 2021 financial results
Biogen Inc. (NASDAQ: BIIB) reported fourth quarter 2021 earnings results today. Total revenue decreased 4% year-over-year to $2.73 billion. GAAP net income
Eli Lilly and Company (LLY) Earnings: 4Q21 Key Numbers
Eli Lilly and Company (NYSE: LLY) reported revenue of $7.9 billion for the fourth quarter of 2021, up 8% year-over-year. Reported net
Humana Inc (HUM) Q4 2021 Earnings Call Transcript
Humana Inc (NYSE: HUM) Q4 2021 earnings call dated Feb. 02, 2022 Corporate Participants: Lisa Stoner -- Vice President of Investor Relations Bruce D.
AbbVie (ABBV) Q4 2021 Earnings Call Transcript
AbbVie (NYSE: ABBV) Q4 2021 earnings call dated Feb. 02, 2022 Corporate Participants: Elizabeth Shea -- Vice President, Investor Relations Richard A. Gonzalez -- Chairman of
Boston Scientific Corp (BSX) Q4 2021 Earnings Call Transcript
Boston Scientific Corp (NYSE: BSX) Q4 2021 earnings call dated Feb. 02, 2022 Corporate Participants: Lauren Tengler -- Vice President, Investor Relations Michael F.
AbbVie (ABBV) Earnings: Key financials and quarterly highlights
AbbVie (NYSE: ABBV) today reported its fourth-quarter financial results for the period ended December 31, 2021. Net revenues increased 7.4% to $14.8
Arcellx readies for $140-mln IPO. Here’s all you need to know
The IPO market is recovering from the slowdown experienced towards the end of 2021, with pharma companies dominating the scene in the
Dr. Reddy’s Laboratories (DRREDDY) Q3 2022 Earnings Call Transcript
Dr. Reddy's Laboratories (NSE: DRREDDY) Q3 2022 earnings call dated Jan. 28, 2022 Corporate Participants: Amit Agarwal -- Head of Investor Relations Parag Agarwal -- Chief
Vertex Pharmaceuticals Incorporated (VRTX) Q4 2021 Earnings Call Transcript
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Michael Partridge -- Senior Vice President of Investor Relations
INTERVIEW: Evelo’s SINTAX medicines could address a broad range of inflammatory disorders
Credit:DavidBGray on iStock Evelo Biosciences (Nasdaq:EVLO) is a clinical-stage biotechnology company that is focused on a newly uncovered area of central human